{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T16:44:22Z","timestamp":1794242662260,"version":"4.9.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fonds de dotation Patrick de Brou de Lauri\u00e8re"},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-24-CE13-3375"],"award-info":[{"award-number":["ANR-24-CE13-3375"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-21-CE13-0006"],"award-info":[{"award-number":["ANR-21-CE13-0006"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondation pour la recherche me\u0301dicale","award":["EQU20200301021"],"award-info":[{"award-number":["EQU20200301021"]}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["19507"],"award-info":[{"award-number":["19507"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European MAGIC Project consortium","award":["101080690"],"award-info":[{"award-number":["101080690"]}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["860034"],"award-info":[{"award-number":["860034"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Skeletal Muscle"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Duchenne Muscular Dystrophy (DMD) is a progressive neuromuscular disorder characterized by impaired muscle repair. Forskolin (FSK), an adenylyl cyclase activator, has shown potential in enhancing muscle regeneration and limiting muscle stem cell senescence. This study aimed to evaluate the effects of FSK on muscle repair, fibrosis, inflammation, and long-term muscle function in DMD using a preclinical rat model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>BaCl<jats:sub>2<\/jats:sub>-induced muscle injury was performed on 6-month-old DMD (R-DMDdel52) and wild-type (WT) rats. FSK was supplied via short-term and long-term administration. Muscle tissues were harvested 14\u00a0days post-injury for histological analysis, including hematoxylin and eosin and Sirius red staining. Immunofluorescence was used to assess fibroadipogenic progenitors (FAPs), regeneration, muscle stem cells, and macrophage phenotypes. Moreover, we performed a study by chronically administering FSK to DMD rats from 1 to 7\u00a0months of age, either intraperitoneally (IP) or subcutaneously (SC). Functional assessments included grip strength test, in vivo muscle force measurements, plethysmography and electrocardiograms. Post-sacrifice, <jats:italic>Tibialis anterior,<\/jats:italic> diaphragm and heart tissues were histologically analyzed, to evaluate muscle architecture, fibrosis, and histopathological indices.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>FSK treatment significantly improved muscle histology and reduced fibrosis in both uninjured and injured DMD muscles by decreasing the number of FAPs. Long-term FSK treatment in the acute injury model enhanced muscle regeneration, increased MuSC proliferation, and reduced senescence. FSK also modulated inflammation by reducing pro-inflammatory macrophages and promoting a shift to a restorative phenotype. However, despite these histological improvements, FSK treatment from 1 to 7\u00a0months resulted in limited functional benefits and worsened ventricular histology in the heart.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>FSK shows promising results in improving muscle regeneration and reducing fibrosis in DMD, but concerns remain regarding its limited chronic functional benefits and potential adverse effects on cardiac tissue. Our results highlight the need for optimized adenylyl cyclase activators for therapeutic use in DMD patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13395-025-00381-7","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T02:39:17Z","timestamp":1746585557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Forskolin treatment enhances muscle regeneration and shows therapeutic potential with limitations in Duchenne muscular dystrophy"],"prefix":"10.1186","volume":"15","author":[{"given":"Andreea Iuliana","family":"Cojocaru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaouthar","family":"Kefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Daniel","family":"Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Tiret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Relaix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Taglietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"issue":"6","key":"381_CR1","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","volume":"51","author":"EP Hoffman","year":"1987","unstructured":"Hoffman EP, Brown RH Jr, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987;51(6):919\u201328.","journal-title":"Cell"},{"issue":"3","key":"381_CR2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/0092-8674(87)90504-6","volume":"50","author":"M Koenig","year":"1987","unstructured":"Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell. 1987;50(3):509\u201317.","journal-title":"Cell"},{"issue":"2","key":"381_CR3","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.bbadis.2006.05.010","volume":"1772","author":"JM Ervasti","year":"2007","unstructured":"Ervasti JM. Dystrophin, its interactions with other proteins, and implications for muscular dystrophy. Biochim Biophys Acta. 2007;1772(2):108\u201317.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"381_CR4","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/s41467-020-20760-6","volume":"12","author":"F Relaix","year":"2021","unstructured":"Relaix F, Bencze M, Borok MJ, Der Vartanian A, Gattazzo F, Mademtzoglou D, Perez-Diaz S, Prola A, Reyes-Fernandez PC, Rotini A. Taglietti t: Perspectives on skeletal muscle stem cells. Nat Commun. 2021;12(1):692.","journal-title":"Nat Commun"},{"issue":"1","key":"381_CR5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1152\/physrev.00007.2015","volume":"96","author":"DG Allen","year":"2016","unstructured":"Allen DG, Whitehead NP, Froehner SC. Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy. Physiol Rev. 2016;96(1):253\u2013305.","journal-title":"Physiol Rev"},{"issue":"14","key":"381_CR6","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1093\/hmg\/ddx173","volume":"26","author":"S Petrillo","year":"2017","unstructured":"Petrillo S, Pelosi L, Piemonte F, Travaglini L, Forcina L, Catteruccia M, Petrini S, Verardo M, D\u2019Amico A, Musaro A, Bertini E. Oxidative stress in Duchenne muscular dystrophy: focus on the NRF2 redox pathway. Hum Mol Genet. 2017;26(14):2781\u201390.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"381_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0960-8966(97)00124-7","volume":"8","author":"TA Rando","year":"1998","unstructured":"Rando TA, Disatnik MH, Yu Y, Franco A. Muscle cells from mdx mice have an increased susceptibility to oxidative stress. Neuromuscul Disord. 1998;8(1):14\u201321.x","journal-title":"Neuromuscul Disord"},{"key":"381_CR8","doi-asserted-by":"publisher","unstructured":"Sarde L, Letort G, Varet H, Laville V, Fernandes J, Tajbakhsh S, Evano B. Impaired stem cell migration and divisions in Duchenne muscular dystrophy revealed by live imaging. bioRxiv. 2025.03.13.643016. https:\/\/doi.org\/10.1101\/2025.03.13.643016.","DOI":"10.1101\/2025.03.13.643016"},{"issue":"12","key":"381_CR9","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/nm.3990","volume":"21","author":"NA Dumont","year":"2015","unstructured":"Dumont NA, Wang YX, von Maltzahn J, Pasut A, Bentzinger CF, Brun CE, Rudnicki MA. Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division. Nat Med. 2015;21(12):1455\u201363.","journal-title":"Nat Med"},{"issue":"1","key":"381_CR10","doi-asserted-by":"publisher","first-page":"16385","DOI":"10.1038\/s41598-020-73315-6","volume":"10","author":"H Sugihara","year":"2020","unstructured":"Sugihara H, Teramoto N, Nakamura K, Shiga T, Shirakawa T, Matsuo M, Ogasawara M, Nishino I, Matsuwaki T, Nishihara M, Yamanouchi K. Cellular senescence-mediated exacerbation of Duchenne muscular dystrophy. Sci Rep. 2020;10(1):16385.","journal-title":"Sci Rep"},{"key":"381_CR11","doi-asserted-by":"crossref","unstructured":"Taglietti V, Kefi K, Rivera L, Bergiers O, Cardone N, Coulpier F, Gioftsidi S, Drayton-Libotte B, Hou C, Authier FJ et al. Thyroid-stimulating hormone receptor signaling restores skeletal muscle stem cell regeneration in rats with muscular dystrophy. Sci Transl Med 2023, 15(685):eadd5275.","DOI":"10.1126\/scitranslmed.add5275"},{"issue":"1","key":"381_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s40478-023-01657-z","volume":"11","author":"N Cardone","year":"2023","unstructured":"Cardone N, Taglietti V, Baratto S, Kefi K, Periou B, Gitiaux C, Barnerias C, Lafuste P, Pharm FL, Pharm JN, et al. Myopathologic trajectory in Duchenne muscular dystrophy (DMD) reveals lack of regeneration due to senescence in satellite cells. Acta Neuropathol Commun. 2023;11(1):167.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"381_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40478-022-01355-2","volume":"10","author":"V Taglietti","year":"2022","unstructured":"Taglietti V, Kefi K, Bronisz-Budzynska I, Mirciloglu B, Rodrigues M, Cardone N, Coulpier F, Periou B, Gentil C, Goddard M, et al. Duchenne muscular dystrophy trajectory in R-DMDdel52 preclinical rat model identifies COMP as biomarker of fibrosis. Acta Neuropathol Commun. 2022;10(1):60.","journal-title":"Acta Neuropathol Commun"},{"issue":"2\u20133","key":"381_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ejphar.2010.05.038","volume":"641","author":"J Kmecova","year":"2010","unstructured":"Kmecova J, Klimas J. Heart rate correction of the QT duration in rats. Eur J Pharmacol. 2010;641(2\u20133):187\u201392.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"381_CR15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s13287-023-03555-6","volume":"14","author":"M Liu","year":"2023","unstructured":"Liu M, Ng M, Phu T, Bouchareychas L, Feeley BT, Kim HT, Raffai RL, Liu X. Polarized macrophages regulate fibro\/adipogenic progenitor (FAP) adipogenesis through exosomes. Stem Cell Res Ther. 2023;14(1):321.","journal-title":"Stem Cell Res Ther"},{"key":"381_CR16","doi-asserted-by":"crossref","unstructured":"Bernadotte A, Mikhelson VM, Spivak IM: Markers of cellular senescence. Telomere shortening as a marker of cellular senescence. Aging (Albany NY) 2016, 8(1):3\u201311.","DOI":"10.18632\/aging.100871"},{"key":"381_CR17","doi-asserted-by":"crossref","unstructured":"Kosmac K, Peck BD, Walton RG, Mula J, Kern PA, Bamman MM, Dennis RA, Jacobs CA, Lattermann C, Johnson DL, Peterson CA: Immunohistochemical Identification of Human Skeletal Muscle Macrophages. Bio Protoc 2018, 8(12):e2883.","DOI":"10.21769\/BioProtoc.2883"},{"key":"381_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/1471-2474-12-113","volume":"12","author":"L Satish","year":"2011","unstructured":"Satish L, Gallo PH, Baratz ME, Johnson S, Kathju S. Reversal of TGF-beta1 stimulation of alpha-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren\u2019s-derived fibroblasts. BMC Musculoskelet Disord. 2011;12:113.","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"381_CR19","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1073\/pnas.0408704102","volume":"102","author":"JS Swaney","year":"2005","unstructured":"Swaney JS, Roth DM, Olson ER, Naugle JE, Meszaros JG, Insel PA. Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overexpression of adenylyl cyclase. Proc Natl Acad Sci U S A. 2005;102(2):437\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"381_CR20","doi-asserted-by":"publisher","first-page":"10931","DOI":"10.1038\/s41598-021-90263-x","volume":"11","author":"Y Song","year":"2021","unstructured":"Song Y, Kim S, Heo J, Shum D, Lee SY, Lee M, Kim AR, Seo HR. Identification of hepatic fibrosis inhibitors through morphometry analysis of a hepatic multicellular spheroids model. Sci Rep. 2021;11(1):10931.","journal-title":"Sci Rep"},{"issue":"22","key":"381_CR21","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1111\/bph.13611","volume":"173","author":"NN El-Agroudy","year":"2016","unstructured":"El-Agroudy NN, El-Naga RN, El-Razeq RA, El-Demerdash E. Forskolin, a hedgehog signalling inhibitor, attenuates carbon tetrachloride-induced liver fibrosis in rats. Br J Pharmacol. 2016;173(22):3248\u201360.","journal-title":"Br J Pharmacol"},{"issue":"7","key":"381_CR22","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/1440-1681.13486","volume":"48","author":"AF Eleraky","year":"2021","unstructured":"Eleraky AF, Helal GK, Elshafie MF, Ismail RS. Concomitant inhibition of hedgehog signalling and activation of retinoid receptors abolishes bleomycin-induced lung fibrosis. Clin Exp Pharmacol Physiol. 2021;48(7):1024\u201340.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"381_CR23","doi-asserted-by":"crossref","unstructured":"Vadnal P, Babu DR, Krishna, Manikantha KGV, Chitalkar K, Reddy CS, Mohan M: Modulation of Stem Cell Factor by Forskolin Inhibits the Progression of Tubule Interstitial Fibrosis. In: J Pharmacol Pharmacother.\u00a015(1); 2024: 54\u201360.","DOI":"10.1177\/0976500X241237641"},{"issue":"5","key":"381_CR24","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1084\/jem.20070075","volume":"204","author":"L Arnold","year":"2007","unstructured":"Arnold L, Henry A, Poron F, Baba-Amer Y, van Rooijen N, Plonquet A, Gherardi RK, Chazaud B. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med. 2007;204(5):1057\u201369.","journal-title":"J Exp Med"},{"issue":"2","key":"381_CR25","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/stem.1288","volume":"31","author":"M Saclier","year":"2013","unstructured":"Saclier M, Yacoub-Youssef H, Mackey AL, Arnold L, Ardjoune H, Magnan M, Sailhan F, Chelly J, Pavlath GK, Mounier R, et al. Differentially activated macrophages orchestrate myogenic precursor cell fate during human skeletal muscle regeneration. Stem Cells. 2013;31(2):384\u201396.","journal-title":"Stem Cells"},{"key":"381_CR26","doi-asserted-by":"crossref","unstructured":"Juban G, Saclier M, Yacoub-Youssef H, Kernou A, Arnold L, Boisson C, Ben Larbi S, Magnan M, Cuvellier S, Theret M et al: AMPK Activation Regulates LTBP4-Dependent TGF-beta1 Secretion by Pro-inflammatory Macrophages and Controls Fibrosis in Duchenne Muscular Dystrophy. Cell Rep 2018, 25(8):2163\u20132176 e2166.","DOI":"10.1016\/j.celrep.2018.10.077"},{"issue":"6","key":"381_CR27","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/s41390-019-0418-4","volume":"86","author":"Y Chen","year":"2019","unstructured":"Chen Y, Wen JG, Feng JJ, Wang YH, Li TF, Nurmi K, Eklund KK, Xing D. Forskolin attenuates the NLRP3 inflammasome activation and IL-1beta secretion in human macrophages. Pediatr Res. 2019;86(6):692\u20138.","journal-title":"Pediatr Res"},{"key":"381_CR28","doi-asserted-by":"publisher","first-page":"1431789","DOI":"10.1155\/2016\/1431789","volume":"2016","author":"JD Chiadak","year":"2016","unstructured":"Chiadak JD, Arsenijevic T, Verstrepen K, Gregoire F, Bolaky N, Delforge V, Flamand V, Perret J, Delporte C. Forskolin Inhibits Lipopolysaccharide-Induced Modulation of MCP-1 and GPR120 in 3T3-L1 Adipocytes through an Inhibition of NFkappaB. Mediators Inflamm. 2016;2016:1431789.","journal-title":"Mediators Inflamm"},{"issue":"11","key":"381_CR29","doi-asserted-by":"publisher","first-page":"7290","DOI":"10.1128\/IAI.73.11.7290-7296.2005","volume":"73","author":"MK Dahle","year":"2005","unstructured":"Dahle MK, Myhre AE, Aasen AO, Wang JE. Effects of forskolin on Kupffer cell production of interleukin-10 and tumor necrosis factor alpha differ from those of endogenous adenylyl cyclase activators: possible role for adenylyl cyclase 9. Infect Immun. 2005;73(11):7290\u20136.","journal-title":"Infect Immun"},{"issue":"3","key":"381_CR30","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1002\/ptr.6248","volume":"33","author":"X Du","year":"2019","unstructured":"Du X, Shi R, Wang Y, Wu W, Sun S, Dai Z, Chen C, Weng Z, Li X, Liu Q, et al. Isoforskolin and forskolin attenuate lipopolysaccharide-induced inflammation through TLR4\/MyD88\/NF-kappaB cascades in human mononuclear leukocytes. Phytother Res. 2019;33(3):602\u20139.","journal-title":"Phytother Res"},{"key":"381_CR31","doi-asserted-by":"publisher","first-page":"8881843","DOI":"10.1155\/2021\/8881843","volume":"2021","author":"X Zhang","year":"2021","unstructured":"Zhang X, Ke PX, Yuan X, Zhang GP, Chen WL, Zhang GS. Forskolin Protected against Streptozotocin-Induced Diabetic Cardiomyopathy via Inhibition of Oxidative Stress and Cardiac Fibrosis in Mice. Biomed Res Int. 2021;2021:8881843.","journal-title":"Biomed Res Int"},{"key":"381_CR32","doi-asserted-by":"crossref","unstructured":"Wang W, Xue Y, Li D, Shao C, Wu K, Sun N, Chen Q: Forskolin is an effective therapeutic small molecule for the treatment of hypertrophic cardiomyopathy through ADCY6\/cAMP\/PKA pathway Eur J Pharmacol\u00a02024, 978:176770.","DOI":"10.1016\/j.ejphar.2024.176770"},{"issue":"26","key":"381_CR33","doi-asserted-by":"publisher","first-page":"6675","DOI":"10.1073\/pnas.1705420114","volume":"114","author":"ATV Ho","year":"2017","unstructured":"Ho ATV, Palla AR, Blake MR, Yucel ND, Wang YX, Magnusson KEG, Holbrook CA, Kraft PE, Delp SL, Blau HM. Prostaglandin E2 is essential for efficacious skeletal muscle stem-cell function, augmenting regeneration and strength. Proc Natl Acad Sci U S A. 2017;114(26):6675\u201384.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"381_CR34","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.peptides.2005.03.011","volume":"26","author":"G Jean-Baptiste","year":"2005","unstructured":"Jean-Baptiste G, Yang Z, Khoury C, Gaudio S, Greenwood MT. Peptide and non-peptide G-protein coupled receptors (GPCRs) in skeletal muscle. Peptides. 2005;26(8):1528\u201336.","journal-title":"Peptides"},{"key":"381_CR35","volume":"2011","author":"S Sato","year":"2011","unstructured":"Sato S, Shirato K, Tachiyashiki K, Imaizumi K. Muscle plasticity and beta(2)-adrenergic receptors: adaptive responses of beta(2)-adrenergic receptor expression to muscle hypertrophy and atrophy. J Biomed Biotechnol. 2011;2011: 729598.","journal-title":"J Biomed Biotechnol"},{"key":"381_CR36","doi-asserted-by":"crossref","unstructured":"Silveira WA, Goncalves DA, Graca FA, Andrade-Lopes AL, Bergantin LB, Zanon NM, Godinho RO, Kettelhut IC, Navegantes LC: Activating cAMP\/PKA signaling in skeletal muscle suppresses the ubiquitin-proteasome-dependent proteolysis: implications for sympathetic regulation. J Appl Physiol (1985) 2014, 117(1):11\u201319.","DOI":"10.1152\/japplphysiol.01055.2013"},{"issue":"9","key":"381_CR37","doi-asserted-by":"publisher","first-page":"12946","DOI":"10.1096\/fj.201902102RR","volume":"34","author":"WA Silveira","year":"2020","unstructured":"Silveira WA, Goncalves DA, Machado J, Lautherbach N, Lustrino D, Paula-Gomes S, Pereira MG, Miyabara EH, Sandri M, Kettelhut IC, Navegantes LC. cAMP-dependent protein kinase inhibits FoxO activity and regulates skeletal muscle plasticity in mice. FASEB J. 2020;34(9):12946\u201362.","journal-title":"FASEB J"},{"issue":"3","key":"381_CR38","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.tcm.2003.12.007","volume":"14","author":"CM Tang","year":"2004","unstructured":"Tang CM, Insel PA. GPCR expression in the heart; \u201cnew\u201d receptors in myocytes and fibroblasts. Trends Cardiovasc Med. 2004;14(3):94\u20139.","journal-title":"Trends Cardiovasc Med"},{"issue":"1","key":"381_CR39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.stem.2012.09.015","volume":"12","author":"CF Bentzinger","year":"2013","unstructured":"Bentzinger CF, Wang YX, von Maltzahn J, Soleimani VD, Yin H, Rudnicki MA. Fibronectin regulates Wnt7a signaling and satellite cell expansion. Cell Stem Cell. 2013;12(1):75\u201387.","journal-title":"Cell Stem Cell"},{"issue":"7","key":"381_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111645","volume":"41","author":"C Senechal","year":"2022","unstructured":"Senechal C, Fujita R, Jamet S, Maiga A, Dort J, Orfi Z, Dumont NA, Bouvier M, Crist C. The adhesion G-protein-coupled receptor Gpr116 is essential to maintain the skeletal muscle stem cell pool. Cell Rep. 2022;41(7): 111645.","journal-title":"Cell Rep"},{"issue":"2","key":"381_CR41","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.celrep.2015.08.083","volume":"13","author":"M Yamaguchi","year":"2015","unstructured":"Yamaguchi M, Watanabe Y, Ohtani T, Uezumi A, Mikami N, Nakamura M, Sato T, Ikawa M, Hoshino M, Tsuchida K, et al. Calcitonin Receptor Signaling Inhibits Muscle Stem Cells from Escaping the Quiescent State and the Niche. Cell Rep. 2015;13(2):302\u201314.","journal-title":"Cell Rep"}],"container-title":["Skeletal Muscle"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13395-025-00381-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13395-025-00381-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13395-025-00381-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T02:39:21Z","timestamp":1746585561000},"score":1,"resource":{"primary":{"URL":"https:\/\/skeletalmusclejournal.biomedcentral.com\/articles\/10.1186\/s13395-025-00381-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["381"],"URL":"https:\/\/doi.org\/10.1186\/s13395-025-00381-7","relation":{},"ISSN":["2044-5040"],"issn-type":[{"value":"2044-5040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval for this study involving animals was granted through two distinct protocols. The acute injury studies were conducted under the ethics approval number #35557\u20132022022314489931, while the chronic experimental studies were approved under #31740\u20132021051920188358 from French Ministry. These approvals ensured that all experimental procedures were carried out in accordance with EU ethical standards for the care and use of animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"V.T. and F.R. have a patent related to the data reported in this paper (#FR2108489). The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}